Extracellular micro/nanovesicles rescue kidney from ischemia-reperfusion injury

Farzamfar, S. and Hasanpour, A. and Nazeri, N. and Razavi, H. and Salehi, M. and Shafei, S. and Nooshabadi, V.T. and Vaez, A. and Ehterami, A. and Sahrapeyma, H. and Ai, J. (2018) Extracellular micro/nanovesicles rescue kidney from ischemia-reperfusion injury. Journal of Cellular Physiology.

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....


Acute renal failure (ARF) is a clinical challenge that is highly resistant to treatment, and its high rate of mortality is alarming. Ischemia�reperfusion injury (IRI) is the most common cause of ARF. Especially IRI is implicated in kidney transplantation and can determine graft survival. Although the exact pathophysiology of renal IRI is unknown, the role of inflammatory responses has been elucidated. Because mesenchymal stromal cells (MSCs) have strong immunomodulatory properties, they are under extensive investigation as a therapeutic modality for renal IRI. Extracellular vesicles (EVs) play an integral role in cell-to-cell communication. Because the regenerative potential of the MSCs can be recapitulated by their EVs, the therapeutic appeal of MSC-derived EVs has dramatically increased in the past decade. Higher safety profile and ease of preservation without losing function are other advantages of EVs compared with their producing cells. In the current review, the preliminary results and potential of MSC-derived EVs to alleviate kidney IRI are summarized. We might be heading toward a cell-free approach to treat renal IRI. © 2018 Wiley Periodicals, Inc.

Item Type: Article
Additional Information: cited By 1; Article in Press
Subjects: Pathology
Divisions: Faculty of Medicine > Basic Sciences > Department of Pathology& Histology
Depositing User: ART . editor
Date Deposited: 10 Apr 2019 12:38
Last Modified: 10 Apr 2019 12:38
URI: http://eprints.kaums.ac.ir/id/eprint/4083

Actions (login required)

View Item View Item